|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:NAA35-LAMC3 (FusionGDB2 ID:56980) |
Fusion Gene Summary for NAA35-LAMC3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NAA35-LAMC3 | Fusion gene ID: 56980 | Hgene | Tgene | Gene symbol | NAA35 | LAMC3 | Gene ID | 60560 | 10319 |
| Gene name | N-alpha-acetyltransferase 35, NatC auxiliary subunit | laminin subunit gamma 3 | |
| Synonyms | EGAP|MAK10|MAK10P|bA379P1.1 | OCCM | |
| Cytomap | 9q21.33 | 9q34.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | N-alpha-acetyltransferase 35, NatC auxiliary subunitMAK10 homolog, amino-acid N-acetyltransferase subunitcorneal wound healing-related proteinembryonic growth-associated protein homologprotein MAK10 homolog | laminin subunit gamma-3laminin, gamma 3laminin-12 subunit gammalaminin-14 subunit gammalaminin-15 subunit gamma | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q5VZE5 | Q9Y6N6 | |
| Ensembl transtripts involved in fusion gene | ENST00000361671, ENST00000376040, | ENST00000480883, ENST00000361069, | |
| Fusion gene scores | * DoF score | 6 X 5 X 5=150 | 6 X 6 X 5=180 |
| # samples | 6 | 6 | |
| ** MAII score | log2(6/150*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/180*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: NAA35 [Title/Abstract] AND LAMC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | NAA35(88628812)-LAMC3(133951218), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across NAA35 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across LAMC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BLCA | TCGA-CU-A3YL-01A | NAA35 | chr9 | 88628812 | - | LAMC3 | chr9 | 133951218 | + |
| ChimerDB4 | BLCA | TCGA-CU-A3YL-01A | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + |
Top |
Fusion Gene ORF analysis for NAA35-LAMC3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000361671 | ENST00000480883 | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + |
| In-frame | ENST00000361671 | ENST00000361069 | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + |
| intron-3CDS | ENST00000376040 | ENST00000361069 | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + |
| intron-intron | ENST00000376040 | ENST00000480883 | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000361671 | NAA35 | chr9 | 88628812 | + | ENST00000361069 | LAMC3 | chr9 | 133951218 | + | 4207 | 1701 | 34 | 2934 | 966 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000361671 | ENST00000361069 | NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951218 | + | 0.002786906 | 0.99721307 |
Top |
Fusion Genomic Features for NAA35-LAMC3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951217 | + | 0.10653917 | 0.8934608 |
| NAA35 | chr9 | 88628812 | + | LAMC3 | chr9 | 133951217 | + | 0.10653917 | 0.8934608 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for NAA35-LAMC3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:88628812/chr9:133951218) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NAA35 | LAMC3 |
| FUNCTION: Auxillary component of the N-terminal acetyltransferase C (NatC) complex which catalyzes acetylation of N-terminal methionine residues. Involved in regulation of apoptosis and proliferation of smooth muscle cells. {ECO:0000269|PubMed:19398576}. | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1201_1228 | 1164 | 1576.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1410_1492 | 1164 | 1576.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1523_1567 | 1164 | 1576.0 | Coiled coil | Ontology_term=ECO:0000255 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1073_1134 | 1164 | 1576.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 271_326 | 1164 | 1576.0 | Domain | Laminin EGF-like 1 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 31_270 | 1164 | 1576.0 | Domain | Laminin N-terminal | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 327_382 | 1164 | 1576.0 | Domain | Laminin EGF-like 2 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 383_429 | 1164 | 1576.0 | Domain | Laminin EGF-like 3 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 430_479 | 1164 | 1576.0 | Domain | Laminin EGF-like 4 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 480_489 | 1164 | 1576.0 | Domain | Laminin EGF-like 5%3B first part | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 499_672 | 1164 | 1576.0 | Domain | Laminin IV type A | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 673_706 | 1164 | 1576.0 | Domain | Laminin EGF-like 5%3B second part | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 707_754 | 1164 | 1576.0 | Domain | Laminin EGF-like 6 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 755_809 | 1164 | 1576.0 | Domain | Laminin EGF-like 7 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 810_865 | 1164 | 1576.0 | Domain | Laminin EGF-like 8 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 866_916 | 1164 | 1576.0 | Domain | Laminin EGF-like 9 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 917_964 | 1164 | 1576.0 | Domain | Laminin EGF-like 10 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 965_1013 | 1164 | 1576.0 | Domain | Laminin EGF-like 11 | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1059_1061 | 1164 | 1576.0 | Motif | Cell attachment site | |
| Tgene | LAMC3 | chr9:88628812 | chr9:133951218 | ENST00000361069 | 19 | 28 | 1014_1575 | 1164 | 1576.0 | Region | Note=Domain II and I |
Top |
Fusion Gene Sequence for NAA35-LAMC3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >56980_56980_1_NAA35-LAMC3_NAA35_chr9_88628812_ENST00000361671_LAMC3_chr9_133951218_ENST00000361069_length(transcript)=4207nt_BP=1701nt ATACGCATGCGTGCACGCTGCCGGTCGGGCTGGGCTGAGAGGGGAGGGGGCGGCGGCGGCCGAGGCGGCGTCGTTATTTCCGTGGTCCGG ACAGTGCGTGGCGGCGCGGGTGACCACGGGAGAAGTAGGCATAATGGTTATGAAAGCTTCTGTAGATGATGACGATTCAGGATGGGAGCT CAGTATGCCAGAAAAAATGGAGAAAAGCAATACAAACTGGGTGGACATTACCCAAGATTTTGAAGAAGCTTGTCGAGAATTAAAGTTGGG AGAACTACTTCATGATAAGCTATTTGGTCTTTTTGAAGCCATGTCTGCTATTGAAATGATGGATCCCAAGATGGATGCTGGCATGATTGG AAACCAAGTTAATCGAAAAGTTCTCAATTTTGAACAAGCTATCAAGGATGGCACTATTAAAATTAAAGATCTCACCTTGCCTGAACTGAT AGGGATTATGGATACATGTTTTTGCTGTTTGATAACGTGGTTAGAAGGCCATTCACTGGCACAGACAGTATTTACGTGCCTTTACATTCA TAATCCAGACTTTATAGAAGATCCTGCTATGAAGGCTTTTGCTCTGGGAATCTTGAAAATCTGTGACATTGCAAGGGAAAAAGTAAATAA AGCTGCTGTTTTTGAAGAGGAAGATTTTCAGTCAATGACTTATGGATTTAAAATGGCTAACAGTGTGACAGATCTTCGAGTTACAGGCAT GCTAAAAGATGTGGAGGATGACATGCAAAGAAGAGTAAAGAGTACTCGAAGTCGACAAGGAGAAGAAAGAGATCCAGAAGTTGAACTAGA ACACCAACAATGTTTAGCAGTATTCAGCAGAGTGAAATTTACTCGTGTGTTACTGACAGTGCTTATAGCCTTTACTAAGAAAGAGACCAG TGCTGTTGCAGAAGCTCAAAAATTGATGGTTCAAGCAGCAGATCTTCTTTCTGCCATTCATAATTCATTGCATCATGGCATCCAGGCCCA GAATGATACTACAAAAGGAGATCATCCAATTATGATGGGTTTTGAACCCCTTGTGAACCAGAGGCTACTTCCACCTACCTTCCCTCGATA TGCAAAAATAATTAAAAGGGAAGAAATGGTGAACTATTTTGCAAGATTAATAGATAGAATAAAAACTGTCTGTGAGGTTGTGAATTTAAC AAATTTACATTGTATCCTGGATTTTTTCTGTGAATTTAGTGAACAGTCACCATGTGTTCTTTCAAGATCTCTGTTACAAACCACTTTCCT GGTGGATAACAAAAAGGTCTTTGGAACTCATCTCATGCAAGACATGGTGAAAGATGCACTTCGGTCTTTTGTCAGTCCTCCGGTGCTTTC CCCCAAGTGCTACCTATATAATAATCACCAGGCTAAGGACTGTATCGACTCCTTTGTTACTCACTGTGTTCGGCCATTCTGTAGTCTTAT TCAGATCCATGGACATAACAGGGCTCGACAGAGAGATAAGCTTGGTCATATTCTTGAGGAATTTGCCACCTTGCAGGATGAGGCAGAGAA GGTTGATGCAGCGCTTCACACCATGCTGTTGAAACAGGAACCCCAAAGGCAACATTTGGCCTGTTTAGGTACCTGGGTCCTTTACCATAA CCTTCGCATTATGATACAGTACCTTCTAAGTGGCTTTGAATTGGAACTCTACAGTATGCACGAGTACTATTACATATATTGCCACAGAGA CACCGCCACCAAGATCGCAGCCACTGCTTGGAGGGCCCTGCTCGCCTCCAACACCAGCTACGCGCTTCTCTGGAATCTGCTGGAGGGAAG GGTGGCCCTAGAGACCCAGCGGGACCTGGAGGACAGGTACCAGGAGGTCCAGGCGGCCCAGAAAGCACTGAGGACGGCTGTGGCAGAGGT GCTGCCTGAAGCGGAAAGCGTGTTGGCCACCGTGCAGCAAGTTGGCGCAGATACAGCCCCGTACCTGGCCTTGCTGGCTTCCCCGGGAGC TCTGCCTCAGAAGTCCCGGGCTGAAGACCTGGGCCTGAAGGCGAAGGCCCTGGAGAAGACAGTTGCATCATGGCAGCACATGGCCACTGA GGCTGCCCGAACCCTCCAGACTGCTGCCCAGGCGACGCTACGGCAAACAGAACCCCTCACAAAGCTGCACCAGGAGGCCAGAGCCGCCCT GACCCAGGCTTCCTCATCTGTCCAGGCTGCGACAGTGACTGTCATGGGAGCCAGGACTCTGCTGGCTGATCTGGAAGGAATGAAGCTGCA GTTTCCCCGGCCCAAGGACCAGGCGGCATTGCAGAGGAAGGCAGACTCCGTCAGTGACAGACTCCTTGCAGACACGAGAAAGAAGACCAA GCAGGCGGAGAGGATGCTGGGAAACGCGGCCCCTCTTTCCTCCAGTGCCAAGAAGAAGGGCAGAGAAGCAGAGGTGTTGGCCAAGGACAG TGCCAAGCTTGCCAAGGCCTTGCTGAGGGAGCGGAAACAGGCGCACCGCCGTGCCAGCAGGCTCACCAGCCAGACGCAAGCCACGCTCCA ACAGGCGTCCCAGCAGGTGCTGGCGTCTGAAGCACGCAGACAGGAGCTGGAGGAAGCTGAGCGGGTGGGTGCTGGGCTGAGCGAGATGGA GCAGCAGATCCGGGAATCGCGTATCTCACTGGAGAAGGACATCGAGACCTTGTCAGAGCTGCTTGCCAGGCTGGGGTCGCTGGACACCCA TCAAGCCCCAGCCCAGGCCCTGAACGAGACTCAGTGGGCACTAGAACGCCTGAGGCTGCAGCTGGGCTCCCCGGGGTCCTTGCAGAGGAA ACTCAGTCTGCTGGAGCAGGAATCCCAGCAGCAGGAGCTGCAGATCCAGGGCTTCGAGAGTGACCTCGCCGAGATCCGCGCCGACAAACA GAACCTGGAGGCCATTCTGCACAGCCTGCCCGAGAACTGTGCCAGCTGGCAGTGAGGGCTGCCCAGATCCCCGGCACACACTCCCCCACC TGCTGTTTACATGACCCAGGGGGTGCACACTACCCCACAGGTGTGCCCATACAGACATTCCCCGGAGCCGGCTGCTGTGAACTCGCCCCC GTGTGGATAGTCACTCCCTGCCGATTCTGTCTGTGGCTTCTTCCCTGCCAGCAGGACTGAGTGTGCGTACCCAGTTCACCTGGACATGAG TGCACACTCTCACCCCTGCACATGCATAAACGGGCACACCCCAGTGTCAATAACATACACACGTGAGGGTGCATGTCTGTGTGTATGACC CACACGTGTTCAAGTCTAATCCATCCAGTCAGCAGCTTACGGTCCACACACATTACAGTCCACAGCTGTTGTGAGAGCCACCTGTGTGCT GGACACCCTCTGGATGTTGGGCAAGTTGTTACATGAGATGCCCTGGGGTGCTACATCCACTCACTCCAGATAGCAGGGAGGTCTCAGCAG ATCTGCAGAGATCAAGGGGGTCAGCAACAGCCAAAGCCCCTAGTCCCAGAGCTGGCTGCCCTCTGTTTCACAGCAGCTCCCTGACCTGTG TTGCTGCGTGCACTCCCTACAGCTCGACACAGCCAGGGGACCAACAGGCCAAGAAATGCAAGATCCCGGGAGGGTTCTTAGCAGCAGAAT CTGAGGCCCAGAGACCCTGAGGCCGTGGCCAGGCCTGCTAGTCTGGCTAGAGCAAGGCCCATTCCTGGCGGGGGTGTCATTGCCTTCACC GGACGCTTCCCTCTCAGGGTCCTGGGACTGCACCAGATGCCCTGAGGGAATGGCCCACCCTGGCCTGTACCCACTTCAGCCTGTGATCTA TCCAAAGAGCCAGGCCCAAAAGCGCCTAGGTCAGGGTGCTCAGGCTACCAGGAGCACGCCTCTGTGCCCCCGGCAACCCAGTTGACCTTT AATTGACGCTTTCCAGACCAGCCCTGCGGCACCACTTGCCATGCGGGAGGCCACCAGGGTGTGCAAGCCTGGCTGCCATTCCAGTCTGTC CTGTCTGGGAATCGCCCTGTGGCCAGGCCCGCATGCTGGCCTCTGCCCAGGACTCCTCAGCATTTCCTCTTGGCATCCCTCCCCTCTCCC AGACCCTCTTCCAGCAGATGGCAAGGCCTCGGCATTGGGAAGTCAGGCACCTCTGCGGGCCCAGCCCCCTCCCGTGGCTCCCCTGACAGG >56980_56980_1_NAA35-LAMC3_NAA35_chr9_88628812_ENST00000361671_LAMC3_chr9_133951218_ENST00000361069_length(amino acids)=966AA_BP=556 MRGEGAAAAEAASLFPWSGQCVAARVTTGEVGIMVMKASVDDDDSGWELSMPEKMEKSNTNWVDITQDFEEACRELKLGELLHDKLFGLF EAMSAIEMMDPKMDAGMIGNQVNRKVLNFEQAIKDGTIKIKDLTLPELIGIMDTCFCCLITWLEGHSLAQTVFTCLYIHNPDFIEDPAMK AFALGILKICDIAREKVNKAAVFEEEDFQSMTYGFKMANSVTDLRVTGMLKDVEDDMQRRVKSTRSRQGEERDPEVELEHQQCLAVFSRV KFTRVLLTVLIAFTKKETSAVAEAQKLMVQAADLLSAIHNSLHHGIQAQNDTTKGDHPIMMGFEPLVNQRLLPPTFPRYAKIIKREEMVN YFARLIDRIKTVCEVVNLTNLHCILDFFCEFSEQSPCVLSRSLLQTTFLVDNKKVFGTHLMQDMVKDALRSFVSPPVLSPKCYLYNNHQA KDCIDSFVTHCVRPFCSLIQIHGHNRARQRDKLGHILEEFATLQDEAEKVDAALHTMLLKQEPQRQHLACLGTWVLYHNLRIMIQYLLSG FELELYSMHEYYYIYCHRDTATKIAATAWRALLASNTSYALLWNLLEGRVALETQRDLEDRYQEVQAAQKALRTAVAEVLPEAESVLATV QQVGADTAPYLALLASPGALPQKSRAEDLGLKAKALEKTVASWQHMATEAARTLQTAAQATLRQTEPLTKLHQEARAALTQASSSVQAAT VTVMGARTLLADLEGMKLQFPRPKDQAALQRKADSVSDRLLADTRKKTKQAERMLGNAAPLSSSAKKKGREAEVLAKDSAKLAKALLRER KQAHRRASRLTSQTQATLQQASQQVLASEARRQELEEAERVGAGLSEMEQQIRESRISLEKDIETLSELLARLGSLDTHQAPAQALNETQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NAA35-LAMC3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NAA35-LAMC3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NAA35-LAMC3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies